ResearchAnalysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival
ResearchActive Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial
ResearchUtility of ursodiol prophylaxis against sinusoidal obstruction syndrome (SOS)/veno-occlusive disease (VOD) in acute leukemia patients receiving gemtuzumab-ozogamicin (GO) or inotuzumab-ozogamicin (InO)
ResearchAdjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial
ResearchState of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023
ResearchPromoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers
ResearchA composite F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)
ResearchAuthor Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features
ResearchPrognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A Review
ResearchMultiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response
